Translesion DNA polymerase kappa activity in gliomas
神经胶质瘤中跨损伤 DNA 聚合酶 kappa 活性
基本信息
- 批准号:8831621
- 负责人:
- 金额:$ 30.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-04-04 至 2019-02-28
- 项目状态:已结题
- 来源:
- 关键词:AddressAdultAffectAgonistAntineoplastic AgentsAryl Hydrocarbon ReceptorBiochemicalBiological AssayBrain NeoplasmsBypassCarmustineCell Culture TechniquesCell SurvivalCellsChemosensitizationComplementDNADNA AdductsDNA DamageDNA biosynthesisDNA repair proteinDNA-Directed DNA PolymeraseDefectDeoxyguanosineDevelopmentDiseaseEmployee StrikesEnzymesEventGenomic InstabilityGenomicsGliomaGoalsHealthHeterogeneityIn VitroInduced MutationKynurenineLeadLesionLightMaintenanceMalignant GliomaMalignant NeoplasmsMalignant neoplasm of brainMeasuresMediatingMessenger RNAModelingMutagenesisMutagensMutation SpectraNatureOutcomePathway interactionsPatientsPolymeraseProcessPrognostic MarkerPropertyProteinsProteomicsPublic HealthReceptor SignalingRegulationResearchResearch ProposalsRoleSignal TransductionSourceStressStructureTestingTryptophanTumor PromotionUnited States National Institutes of HealthUp-Regulationaryl hydrocarbon receptor ligandbiological adaptation to stresscancer therapycancer typechemotherapyclinically relevantcytotoxiccytotoxicityhuman DNAhuman WRN proteinimprovedin vitro Assayinhibitor/antagonistinnovationinsightinterestpreclinical studypreventprotein protein interactionresearch studyresponsesmall moleculetemozolomidetumor
项目摘要
DESCRIPTION (provided by applicant): Translesion DNA synthesis polymerases (TLS pols) are vital to bypass and tolerance of DNA damage. The mis-regulation of TLS pols occurs in many types of cancer, including malignant brain tumors of glial origin. Human DNA polymerase kappa (hpol ?) was recently shown to be an independent prognostic indicator of poor outcome in glioma patients. However, the mechanism(s) leading to up-regulation of hpol ? in gliomas and the precise effects upon DNA replication remain unknown. The experiments outlined herein will examine whether tumor-promoting activation of the aryl hydrocarbon receptor (AhR) leads to constitutive up-regulation of hpol ? in gliomas and then investigate mechanistic features associated with hpol ? activity in these deadly tumors. The central objectives include investigating mechanisms that promote hpol ? over-expression in glioma cells, determining the effect of this mis-regulation upon replication stress responses, studying protein-protein interactions that alter hpol ? activity and examining potential ways of improving glioma treatment through targeted inhibition of TLS pols in brain tumors. The current proposal will address important questions, such as: 1) Does the AhR pathway regulate hpol ? in gliomas? 2) Do exogenous or endogenous AhR ligands affect hpol expression and/or activity? 3) How does blocking endogenous AhR-signaling in gliomas affect replication stress? 4) Can modulation of TLS activity in gliomas potentiate anti-cancer treatments? 5) Do protein-protein interactions between hpol ? and the genomic caretaker Werner's syndrome protein (WRN) limit mutagenic bypass of DNA damage in glioma cells? The experimental strategies utilize in vitro cell culture, mutagenesis assays, structure-function analyses, small-molecule inhibitor studies and proteomics to ascertain the role of hpol ? in gliomas. The long-term goal of the application is to produce models for replication stress and TLS activity that inform our understanding of genomic maintenance and mutagenesis in gliomas, while also providing insights into how we might better treat patients suffering from this disease. The conclusions derived from these studies will dramatically improve our fundamental definition of processes that occur in malignant brain tumors, a major public health concern.
描述(由申请人提供):翻译DNA合成聚合酶(TLS pol)对于绕过和耐受DNA损伤至关重要。TLS极点的错误调控发生在许多类型的癌症中,包括源自神经胶质的恶性脑肿瘤。人类DNA聚合酶kappa (hpol ?)最近被证明是胶质瘤患者预后不良的独立预后指标。然而,导致hpol ?以及对DNA复制的确切影响尚不清楚。本文概述的实验将检验芳烃受体(AhR)的促肿瘤激活是否会导致hpol ?然后研究与hpol相关的机制特征?这些致命肿瘤的活性。中心目标包括调查促进hpol的机制。在胶质瘤细胞中的过度表达,确定这种错误调控对复制应激反应的影响,研究改变hpol ?活性和研究通过靶向抑制脑肿瘤中的TLS极点来改善胶质瘤治疗的潜在方法。目前的提案将解决一些重要的问题,例如:1)AhR通路是否调节hpol ?在神经胶质瘤吗?2)外源性或内源性AhR配体是否影响hpol的表达和/或活性?3)阻断胶质瘤内源性ahr信号如何影响复制应激?4)胶质瘤中TLS活性的调节是否能增强抗癌治疗?5) hpol之间的蛋白-蛋白相互作用?和基因组看守Werner's综合征蛋白(WRN)限制神经胶质瘤细胞DNA损伤的诱变旁路?实验策略利用体外细胞培养、诱变分析、结构-功能分析、小分子抑制剂研究和蛋白质组学来确定hpol ?在神经胶质瘤。该应用程序的长期目标是产生复制压力和TLS活性的模型,以告知我们对胶质瘤中基因组维持和突变的理解,同时也为我们如何更好地治疗患有这种疾病的患者提供见解。从这些研究中得出的结论将大大改善我们对恶性脑肿瘤过程的基本定义,恶性脑肿瘤是一个主要的公共卫生问题。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT L EOFF其他文献
ROBERT L EOFF的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT L EOFF', 18)}}的其他基金
Translesion DNA polymerase kappa activity in gliomas
神经胶质瘤中跨损伤 DNA 聚合酶 kappa 活性
- 批准号:
9022446 - 财政年份:2014
- 资助金额:
$ 30.31万 - 项目类别:
Translesion DNA polymerase kappa activity in gliomas
神经胶质瘤中跨损伤 DNA 聚合酶 kappa 活性
- 批准号:
8670134 - 财政年份:2014
- 资助金额:
$ 30.31万 - 项目类别:
Coordinating Translesion DNA Synthesis Opposite Damaged DNA
协调跨损伤 DNA 合成与受损 DNA 相对
- 批准号:
8214700 - 财政年份:2009
- 资助金额:
$ 30.31万 - 项目类别:
Coordinating Translesion DNA Synthesis Opposite Damaged DNA
协调跨损伤 DNA 合成与受损 DNA 相对
- 批准号:
7737723 - 财政年份:2009
- 资助金额:
$ 30.31万 - 项目类别:
Coordinating Translesion DNA Synthesis Opposite Damaged DNA
协调跨损伤 DNA 合成与受损 DNA 相对
- 批准号:
8206324 - 财政年份:2009
- 资助金额:
$ 30.31万 - 项目类别:
Coordinating Translesion DNA Synthesis Opposite Damaged DNA
协调跨损伤 DNA 合成与受损 DNA 相对
- 批准号:
8401886 - 财政年份:2009
- 资助金额:
$ 30.31万 - 项目类别:
Translesion Synthesis Opposite Carcinogen Bound DNA
跨损伤合成相反致癌物结合 DNA
- 批准号:
7465562 - 财政年份:2006
- 资助金额:
$ 30.31万 - 项目类别:
Translesion Synthesis Opposite Carcinogen Bound DNA
跨损伤合成相反致癌物结合 DNA
- 批准号:
7270480 - 财政年份:2006
- 资助金额:
$ 30.31万 - 项目类别:
Translesion Synthesis Opposite Carcinogen Bound DNA
跨损伤合成相反致癌物结合 DNA
- 批准号:
7154445 - 财政年份:2006
- 资助金额:
$ 30.31万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 30.31万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 30.31万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 30.31万 - 项目类别:
Standard Grant
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 30.31万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 30.31万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 30.31万 - 项目类别:
Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
- 批准号:
10065645 - 财政年份:2023
- 资助金额:
$ 30.31万 - 项目类别:
Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 30.31万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 30.31万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 30.31万 - 项目类别:
Grant-in-Aid for Scientific Research (C)